Genmab A/S Short Interest Ratio and Short Volume

Short interest is the volume of Genmab A/S shares that have been sold short but have not yet been covered or closed out. As of March 31st, investors have sold 84,500 shares of GNMSF short.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Genmab A/S currently has a short interest ratio of 25.0.

Genmab A/S saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 84,500 shares, an increase of 14.8% from the previous total of 73,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

0.00% of Genmab A/S's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Genmab A/S: Zoetis Inc. (0.99%), Bayer Aktiengesellschaft (0.00%), Vertex Pharmaceuticals Incorporated (0.00%), Takeda Pharmaceutical Company Limited (0.30%), Regeneron Pharmaceuticals, Inc. (2.16%), Alexion Pharmaceuticals, Inc. (3.58%), BeiGene, Ltd. (0.00%), Astellas Pharma Inc. (0.00%), Shiseido Company, Limited (0.00%), and Royalty Pharma plc (6.01%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.84 billion), Aon plc ($5.47 billion), Charter Communications, Inc. ($5.36 billion), ViacomCBS Inc. ($3.99 billion), Snap Inc. ($3.77 billion), Airbnb, Inc. ($2.90 billion), Peloton Interactive, Inc. ($2.43 billion), Discovery, Inc. ($2.38 billion), The Kroger Co. ($2.28 billion), and Expedia Group, Inc. ($2.18 billion). View all of the most shorted stocks.

Short selling GNMSF is an investing strategy that aims to generate trading profit from Genmab A/S as its price is falling. Genmab A/S's stock is trading up $3.42 today. To short Genmab A/S stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Genmab A/S will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Genmab A/S occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GNMSF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GNMSF, twice per month. The most recent reporting period available is March, 31 2021.